BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21823910)

  • 1. Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study.
    Correll CU; Harris J; Figen V; Kane JM; Manu P
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):365-8. PubMed ID: 21823910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QTc interval in a sample of long-term schizophrenia inpatients.
    Ramos-Ríos R; Arrojo-Romero M; Paz-Silva E; Carballal-Calvo F; Bouzón-Barreiro JL; Seoane-Prado J; Codesido-Barcala R; Crespí-Armenteros A; Fernández-Pérez R; López-Moríñigo JD; Tortajada-Bonaselt I; Diaz FJ; de Leon J
    Schizophr Res; 2010 Jan; 116(1):35-43. PubMed ID: 19892525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
    Haddad PM; Anderson IM
    Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.
    Muzyk AJ; Rayfield A; Revollo JY; Heinz H; Gagliardi JP
    Drug Saf; 2012 Jul; 35(7):547-53. PubMed ID: 22702639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drugs and QT interval prolongation.
    Zareba W; Lin DA
    Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics.
    Lin CH; Chen MC; Wang SY; Lin CY
    J Formos Med Assoc; 2004 Jun; 103(6):437-41. PubMed ID: 15278188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The QTc interval and its dispersion in patients receiving two atypical antipsychotics.
    Correll CU; Frederickson AM; Figen V; Ginn-Scott EJ; Pantaleon Moya RA; Kane JM; Manu P
    Eur Arch Psychiatry Clin Neurosci; 2009 Feb; 259(1):23-7. PubMed ID: 18574608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.
    Czekalla J; Beasley CM; Dellva MA; Berg PH; Grundy S
    J Clin Psychiatry; 2001 Mar; 62(3):191-8. PubMed ID: 11305706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors related to the length of the corrected QT interval in patients treated with antipsychotics].
    Fraguas Herráez D; Laita de Roda P; González Balmaseda G; González Laynez E; Gamo Bravo B; Pascual Hernández D; Parellada Redondo M; Moreno Pardillo D; Franco Porras C; Llorente Sarabia C; Kushner SA; Arango López C
    Med Clin (Barc); 2008 Apr; 130(12):446-9. PubMed ID: 18405498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Yang FD; Wang XQ; Liu XP; Zhao KX; Fu WH; Hao XR; Zhang XL; Huang GS; Qu SC; Bai JS; Huang XF; Kosten TR; Zhang XY
    Psychopharmacology (Berl); 2011 Jul; 216(1):9-16. PubMed ID: 21301815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
    Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
    Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
    Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
    Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QT interval duration and dispersion in children and adolescents treated with ziprasidone.
    Correll CU; Lops JD; Figen V; Malhotra AK; Kane JM; Manu P
    J Clin Psychiatry; 2011 Jun; 72(6):854-60. PubMed ID: 21457682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study.
    Mackin P; Young AH
    J Clin Psychiatry; 2005 Nov; 66(11):1386-91. PubMed ID: 16420075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of QTc interval and antipsychotics.
    Agelink MW
    Am J Psychiatry; 2002 Jun; 159(6):1063; author reply 1064. PubMed ID: 12042206
    [No Abstract]   [Full Text] [Related]  

  • 17. First-generation antipsychotics and QTc: any role for mediating variables?
    Carrà G; Crocamo C; Bartoli F; Lax A; Tremolada M; Lucii C; Martinotti G; Nosè M; Bighelli I; Ostuzzi G; Castellazzi M; Clerici M; Barbui C;
    Hum Psychopharmacol; 2016 Jul; 31(4):313-8. PubMed ID: 27245736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.
    Barbui C; Bighelli I; Carrà G; Castellazzi M; Lucii C; Martinotti G; Nosè M; Ostuzzi G;
    PLoS One; 2016; 11(2):e0148212. PubMed ID: 26840602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antipsychotic use by patients with schizophrenia on deceleration capacity and its relation to the corrected QT interval.
    Okayasu H; Shinozaki T; Takano Y; Sugawara N; Fujii K; Yasui-Furukori N; Ozeki Y; Shimoda K
    Gen Hosp Psychiatry; 2023; 81():15-21. PubMed ID: 36716654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy.
    Elliott A; Mørk TJ; Højlund M; Christensen T; Jeppesen R; Madsen N; Viuff AG; Hjorth P; Nielsen JC; Munk-Jørgensen P
    CNS Spectr; 2018 Aug; 23(4):278-283. PubMed ID: 28659221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.